En poursuivant votre navigation, vous acceptez le dépôt de cookies tiers destinés à vous permettre et faciliter la navigation sur le site notamment en mémorisant vos préférences de navigation définies au cours de votre session.

Menton, France, September 13-15, 2020



Preliminary Program:

Sunday September 13 th : Meeting of the Expert committee
(closed session)

Monday September 14 th : Plenary

  • 7.30: Poster set-up.
  • 8.00- 8.15: Openings: G Salles (LYSA) and F.Merli (FIL)
    A.Gallamini (France), M.Meignan (France), C.Haioun(France), L.Rigacci (Italy), C.Thieblemont (France)
  • 8.15-9.15: PET Imaging criteria in Myeloma (presentation of expert panel discussion):
    Chair: F Merli (Italy), C Kobe (Germany)
    E.Zamagni (Italy), C. Bodet-Milin (France) C.Nanni (Italy), E Terpos (Greece)
  • 9.15-10.00: PET and MRD in MM
    Chair: S Luminari (Italy), C.Haioun (France)
    Ph. Moreau (France), A Versari (Italy), F. Bodere (France).
  • 10.00-10.30: Coffee break10.30-12.30: The International Project of Metabolic Tumor Volume Harmonization
    Chair: S Barrington (UK), M Meignan (France), A Gallamini (France).
    Discussants (specific presentation to be defined): I.Buvat (France),R.Boellaard (Netherlands), S.Chauvie (Italy), G Mikhaeel (UK), O Casasnovas (France),AS Cottereau (France), A Berriolo (France), C Schmitz (Germany), C Kobe (Germany) T El Galaly (Denmark), A Moskowitz (US), H.Schoder (US) A ,Versari (Italy), L Guerra (Italy), S Luminari (Italy), L Rigacci (Italy), L Ceriani
    (Switzerland), E Zucca (Switzerland)
  • 12.30-13.00 Poster walking
  • 13.00-14.00: Lunch
  • 14.00- 16.00: CAR T-cell: What is expected from PET imaging?
    Chair: S Schuster (USA), C Thieblemont (France)
    Discussants (specific presentation to be defined): S. Schuster (US), C Thieblemont (France), F. Merli (Italy), I Buvat (France), AS.Cottereau (France), H Schoder (USA), L Vercellino (France), A Moskowitz (USA), K Hermann (Germany), A Alizadeh (USA)
  • 15.30-16.00 Coffee break
  • 16.00-17.00: A. Alizadeh (USA): TMTV and ct DNA in Hodgkin lymphoma.
    Chair: D.Rossi (Italy), AS Cottereau (France)

Tuesday 15 th 2020: Plenary

  • 08.00- 9.30: How to define new prognostic indices including baseline PET parameters?
    Chair: L Sehn (CND), A.Lister (UK), M.Andre (Belgium), E Zucca (Switzerland)
    Discussants (specific presentation to be defined): A Lister (UK), L Ceriani (Switzerland), C Thieblemont (France), AS Cottereau (France), M Federico (Italy), Gallamini (France),
  • 9.30 10.00: Coffee break
  • 10.00-12.00: Poster discussion: U. Duhrsen (Germany), T. Vander Borght (Belgium)
    Best Poster Award in memory of Alberto Biggi
    Oral presentations of selected posters
  • 12 00 13.00: Is Artificial Intelligence helpful (MV measurement and risk identification)
    Chair: I. Buvat (France), T. El-Galaly (Denmark)
    Discussant (specific presentation to be defined): N. Capobianco (Italy), N (DK), C. Rossi (France)
  • 13.00-14.00: Lunch
  • 14.00-15.00: The new challenges for Deauville criteria
    Chair: B. Cheson (USA), E Lopci (Italy)
    Discussants (specific presentation to be defined): O Casasnovas (France), C. Bodet-Milin (France), H Schoder (USA), U Duhrsen (Germany), L Kostakoglu(USA)
  • 15.00- 16-00: Results of ongoing PET guided trials in lymphoma:
    Chair: J Zaucha (Poland), L Rigacci (Italy)
  • 16.00-16.30: B Cheson (USA): PET in lymphoma during the last 10 years.
    Perspectives from the meeting
    Chair: M Federico (Italy), H Tilly (France)
  • 17-00: Closing